The effect of oxidant stress on diamide-treated human granulocytes.
The role of sulfhydryls in the protection of human polymorphonuclear neutrophils against extracellular oxidant attack was investigated by simultaneously exposing polymorphonuclear neutrophils to the thiol-oxidizing agent diamide and the oxidant-generating system xanthine-xanthine oxidase. Neither diamide nor the oxidants generated by the xanthine-xanthine oxidase system alone impaired the burst in chemiluminescence, hexose monophosphate shunt activity or formate oxidation normally seen during polymorphonuclear neutrophil phagocytosis. Incubation of the polymorphonuclear neutrophils simultaneously with diamide and xanthine-xanthine oxidase markedly impaired polymorphonuclear neutrophil phagocytosis, hexose monophosphate shunt activity, chemiluminescence and formate oxidation. Although the polymorphonuclear neutrophils exposed to diamide and xanthine-xanthine oxidase did not respond to a variety of phagocytizable stimuli, trypan blue exclusion was normal and hexose monophosphate shunt activity could be stimulated by diamide. The damaging effect of the diamide xanthine-xamthine oxidase system could be blocked by the addition of superoxide dismutase or catalase, but not by hydroxyl radical or singlet oxygen scavengers. We hypothesize that an unidentified population of thiols may play a role in protecting the polymorphonuclear neutrophil from endogenously derived oxidants.
D001391:Azo Compounds / Q000494:pharmacology*; D002374:Catalase / Q000494:pharmacology; D003958:Diamide / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005561:Formates / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D006098:Granulocytes / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D008163:Luminescent Measurements; D010084:Oxidation-Reduction; D010100:Oxygen / Q000494:pharmacology*; D010587:Phagocytosis; D013482:Superoxide Dismutase / Q000494:pharmacology; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors / Q000494:pharmacology; D014970:Xanthines / Q000037:antagonists & inhibitors / Q000494:pharmacology
D001391:Azo Compounds; D005561:Formates; D014970:Xanthines; D003958:Diamide; D002374:Catalase; D013482:Superoxide Dismutase; D014969:Xanthine Oxidase; D005947:Glucose; D010100:Oxygen